Clinical trial for Heart Failure
Official title Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
ClinicalTrials.gov ID: NCT07337577
What this study is testing
- What it's testing
- The study wants to see if the AI tool helps clinicians start or adjust guideline‑recommended heart‑failure drugs within 30 days, and whether it can be delivered safely.
- Who it's for
- Adults with heart failure who are seen in outpatient cardiology clinics at Mass General Brigham.
- What's involved
- Doctors receive brief AI‑generated messages through the electronic health record before a patient’s visit, suggesting medication changes; the tool does not order anything itself.
- Time commitment
- The trial follows patients for about 30 days after a visit; no extra clinic visits or tests are required from participants.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Age ≥18 years
- Scheduled outpatient visit with a participating cardiology provider in an MGB outpatient cardiology clinic
- At least one prior cardiology clinic visit in the MGB system within the past 2 years
- Diagnosis of heart failure by ICD code within the past 2 years
- Current or recent use of a loop diuretic
You likely can't join if
- Systolic blood pressure \<90 mmHg on the most recent recorded measurement
- Heart rate \<50 beats per minute on the most recent recorded measurement
- eGFR \<20 mL/min/1.73 m² on the most recent laboratory assessment
- Known cardiac amyloidosis or hypertrophic cardiomyopathy
- History of heart transplant or presence of a left ventricular assist device
- Severe aortic stenosis, severe aortic insufficiency, or severe mitral stenosis on the most recent echocardiogram
See the full eligibility criteria
- Age ≥18 years
- Scheduled outpatient visit with a participating cardiology provider in an MGB outpatient cardiology clinic
- At least one prior cardiology clinic visit in the MGB system within the past 2 years
- Diagnosis of heart failure by ICD code within the past 2 years
- Current or recent use of a loop diuretic
- Left ventricular ejection fraction ≤40% on the most recent echocardiogram
- Explicit documentation of heart failure diagnosis or heart failure signs/symptoms in a prior cardiology note
- Systolic blood pressure \<90 mmHg on the most recent recorded measurement
- Heart rate \<50 beats per minute on the most recent recorded measurement
- eGFR \<20 mL/min/1.73 m² on the most recent laboratory assessment
- Known cardiac amyloidosis or hypertrophic cardiomyopathy
- History of heart transplant or presence of a left ventricular assist device
- Severe aortic stenosis, severe aortic insufficiency, or severe mitral stenosis on the most recent echocardiogram
- Encounter occurs in an adult congenital heart disease clinic
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Compensation & support
A stipend or payment for your time may be offered.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.